Decline in logistics fee revenue from prioritizing the stable supply of pharmaceuticals
A specific-period earnings risk in which logistics-related fee revenue from pharmaceutical manufacturers declines after sales activities are suspended or scaled back to prioritize the stable supply of pharmaceuticals during the COVID-19 pandemic.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.